Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEORGES MARINIER
Original Assignee
GEORGES MARINIER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEORGES MARINIERfiledCriticalGEORGES MARINIER
Priority to FR916126ApriorityCriticalpatent/FR2215M/fr
Application grantedgrantedCritical
Publication of FR2215MpublicationCriticalpatent/FR2215M/fr
208000037265diseases, disorders, signs and symptomsDiseases0.000title1
208000035475disorderDiseases0.000title1
230000037356lipid metabolismEffects0.000title1
229940126601medicinal productDrugs0.000title1
FR916126A1962-11-211962-11-21Médicament pour le traitement des troubles du métabolisme lipidique a base de p-méthoxy-α-phényl-cinnamate de choline.
ExpiredFR2215M
(fr)
Médicament a base d'une nouvelle série de 1-aryl-4-oxo-1,3,8-triazaspiro-(4,5)-décanes, substitués en position 8 ou leurs sels pour le traitement d'affections mentales.
Médicament a base de 17-acétate de la 6 alpha-méthyl-9 alpha-fluoro-11 béta, 17 alpha-dihydroxy-1,4-prégnadiene-3,20-dione pour le traitement de l'aménorrhée.